| BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression AM Roccaro, A Sacco, P Maiso, AK Azab, YT Tai, M Reagan, F Azab, ... The Journal of clinical investigation 123 (4), 1542-1555, 2013 | 867 | 2013 |
| Electrospun silk biomaterial scaffolds for regenerative medicine X Zhang, MR Reagan, DL Kaplan Advanced drug delivery reviews 61 (12), 988-1006, 2009 | 584 | 2009 |
| CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications YT Tai, Y Landesman, C Acharya, Y Calle, MY Zhong, M Cea, ... Leukemia 28 (1), 155-165, 2014 | 321 | 2014 |
| Blocking FSH induces thermogenic adipose tissue and reduces body fat P Liu, Y Ji, T Yuen, E Rendina-Ruedy, VE DeMambro, S Dhawan, ... Nature 546 (7656), 107-112, 2017 | 318 | 2017 |
| Engineered nanomedicine for myeloma and bone microenvironment targeting A Swami, MR Reagan, P Basto, Y Mishima, N Kamaly, S Glavey, S Zhang, ... Proceedings of the National Academy of Sciences 111 (28), 10287-10292, 2014 | 298 | 2014 |
| Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma D Harmer, C Falank, MR Reagan Frontiers in endocrinology 9, 788, 2019 | 266 | 2019 |
| Concise review: mesenchymal stem cell tumor-homing: detection methods in disease model systems MR Reagan, DL Kaplan Stem cells 29 (6), 920-927, 2011 | 262 | 2011 |
| Multiple myeloma in the marrow: pathogenesis and treatments H Fairfield, C Falank, L Avery, MR Reagan Annals of the New York Academy of Sciences 1364 (1), 32-51, 2016 | 257 | 2016 |
| Human bone marrow–derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis RH Goldstein, MR Reagan, K Anderson, DL Kaplan, M Rosenblatt Cancer research 70 (24), 10044-10050, 2010 | 222 | 2010 |
| LNA-mediated anti–miR-155 silencing in low-grade B-cell lymphomas Y Zhang, AM Roccaro, C Rombaoa, L Flores, S Obad, SM Fernandes, ... Blood, The Journal of the American Society of Hematology 120 (8), 1678-1686, 2012 | 183 | 2012 |
| Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma MM McDonald, MR Reagan, SE Youlten, ST Mohanty, A Seckinger, ... Blood, The Journal of the American Society of Hematology 129 (26), 3452-3464, 2017 | 177 | 2017 |
| Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects MR Reagan, IM Ghobrial Clinical Cancer Research 18 (2), 342-349, 2012 | 173 | 2012 |
| SDF-1 inhibition targets the bone marrow niche for cancer therapy AM Roccaro, A Sacco, WG Purschke, M Moschetta, K Buchner, C Maasch, ... Cell reports 9 (1), 118-128, 2014 | 164 | 2014 |
| Navigating the bone marrow niche: translational insights and cancer-driven dysfunction MR Reagan, CJ Rosen Nature Reviews Rheumatology 12 (3), 154-168, 2016 | 157 | 2016 |
| Silk fibroin and silk-based biomaterial derivatives for ideal wound dressings PP Patil, MR Reagan, RA Bohara International journal of biological macromolecules 164, 4613-4627, 2020 | 156 | 2020 |
| Spider silk-based gene carriers for tumor cell-specific delivery K Numata, MR Reagan, RH Goldstein, M Rosenblatt, DL Kaplan Bioconjugate chemistry 22 (8), 1605-1610, 2011 | 146 | 2011 |
| The skeletal cell‐derived molecule sclerostin drives bone marrow adipogenesis H Fairfield, C Falank, E Harris, V Demambro, M McDonald, JA Pettitt, ... Journal of cellular physiology 233 (2), 1156-1167, 2018 | 141 | 2018 |
| CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal-transition-like transcriptional activation AM Roccaro, Y Mishima, A Sacco, M Moschetta, YT Tai, J Shi, Y Zhang, ... Cell reports 12 (4), 622-635, 2015 | 141 | 2015 |
| The cancer glycome: carbohydrates as mediators of metastasis SV Glavey, D Huynh, MR Reagan, S Manier, M Moschetta, Y Kawano, ... Blood reviews 29 (4), 269-279, 2015 | 134 | 2015 |
| The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma SV Glavey, S Manier, A Natoni, A Sacco, M Moschetta, MR Reagan, ... Blood, The Journal of the American Society of Hematology 124 (11), 1765-1776, 2014 | 126 | 2014 |
Irene GhobrialDana-Farber Cancer InstituteGeverifieerd e-mailadres voor dfci.harvard.edu
